Lupus kliniske forsøg i Colorado
8 studier for Lupus søger deltagere på steder i Colorado.
Byer i Colorado
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50719, Aurora
RekruttererFase 3
Alder 16 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- University of Colorado Denver, Aurora
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Denver Arthritis Clinic - Lowry, Denver
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 1. okt. 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- University of Colorado Denver, Aurora
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT06133972A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Denver Arthritis Clinic, Denver
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07438496A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Colorado Denver, Aurora
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- University of Colorado, Aurora
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 21. aug. 2026 · NCT06570798A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Aurora
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 22. jun. 2026 · NCT06576271Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.